191 related articles for article (PubMed ID: 36838660)
1. Molecular Modeling and In Vitro Evaluation of Piplartine Analogs against Oral Squamous Cell Carcinoma.
Silva RHN; Machado TQ; da Fonseca ACC; Tejera E; Perez-Castillo Y; Robbs BK; de Sousa DP
Molecules; 2023 Feb; 28(4):. PubMed ID: 36838660
[TBL] [Abstract][Full Text] [Related]
2. Piplartine Analogues and Cytotoxic Evaluation against Glioblastoma.
da Nóbrega FR; Ozdemir O; Nascimento Sousa SCS; Barboza JN; Turkez H; de Sousa DP
Molecules; 2018 Jun; 23(6):. PubMed ID: 29890617
[TBL] [Abstract][Full Text] [Related]
3. Diferuloylmethane augments the cytotoxic effects of piplartine isolated from Piper chaba.
Jyothi D; Vanathi P; Mangala Gowri P; Rama Subba Rao V; Madhusudana Rao J; Sreedhar AS
Toxicol In Vitro; 2009 Sep; 23(6):1085-91. PubMed ID: 19501152
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic effect of pure compounds from
Fonseca ACCD; de Queiroz LN; Sales Felisberto J; Jessé Ramos Y; Mesquita Marques A; Wermelinger GF; Pontes B; de Lima Moreira D; Robbs BK
Nat Prod Res; 2021 Dec; 35(24):6163-6167. PubMed ID: 33078660
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the genotoxicity of piplartine, an alkamide of Piper tuberculatum, in yeast and mammalian V79 cells.
Bezerra DP; Moura DJ; Rosa RM; de Vasconcellos MC; e Silva AC; de Moraes MO; Silveira ER; Lima MA; Henriques JA; Costa-Lotufo LV; Saffi J
Mutat Res; 2008 Apr; 652(2):164-74. PubMed ID: 18372210
[TBL] [Abstract][Full Text] [Related]
6. The Antitumor Activity of Piplartine: A Review.
Duarte ABS; Gomes RC; Nunes VRV; Gonçalves JCR; Correia CA; Dos Santos AZG; de Sousa DP
Pharmaceuticals (Basel); 2023 Sep; 16(9):. PubMed ID: 37765054
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanism of action of new 1,4-naphthoquinones tethered to 1,2,3-1H-triazoles with cytotoxic and selective effect against oral squamous cell carcinoma.
Cavalcanti Chipoline I; Carolina Carvalho da Fonseca A; Ribeiro Machado da Costa G; Pereira de Souza M; Won-Held Rabelo V; de Queiroz LN; Luiz Ferraz de Souza T; Cardozo Paes de Almeida E; Alvarez Abreu P; Pontes B; Francisco Ferreira V; de Carvalho da Silva F; Robbs BK
Bioorg Chem; 2020 Aug; 101():103984. PubMed ID: 32554278
[TBL] [Abstract][Full Text] [Related]
8. Overview of the therapeutic potential of piplartine (piperlongumine).
Bezerra DP; Pessoa C; de Moraes MO; Saker-Neto N; Silveira ER; Costa-Lotufo LV
Eur J Pharm Sci; 2013 Feb; 48(3):453-63. PubMed ID: 23238172
[TBL] [Abstract][Full Text] [Related]
9. Pro-Apoptotic Antitumoral Effect of Novel Acridine-Core Naphthoquinone Compounds against Oral Squamous Cell Carcinoma.
Zorzanelli BC; Ouverney G; Pauli FP; da Fonseca ACC; de Almeida ECP; de Carvalho DG; Possik PA; Rabelo VW; Abreu PA; Pontes B; Ferreira VF; Forezi LDSM; da Silva FC; Robbs BK
Molecules; 2022 Aug; 27(16):. PubMed ID: 36014389
[TBL] [Abstract][Full Text] [Related]
10. Antiplatelet effects of piplartine, an alkamide isolated from Piper tuberculatum: possible involvement of cyclooxygenase blockade and antioxidant activity.
Fontenele JB; Leal LK; Silveira ER; Felix FH; Bezerra Felipe CF; Viana GS
J Pharm Pharmacol; 2009 Apr; 61(4):511-5. PubMed ID: 19298699
[TBL] [Abstract][Full Text] [Related]
11. Anticancer effects induced by artichoke extract in oral squamous carcinoma cell lines.
Hassabou NF; Farag AF
J Egypt Natl Canc Inst; 2020 Apr; 32(1):17. PubMed ID: 32372389
[TBL] [Abstract][Full Text] [Related]
12. Structure⁻Activity Relationship of Piplartine and Synthetic Analogues against
Campelo Y; Ombredane A; Vasconcelos AG; Albuquerque L; Moreira DC; Plácido A; Rocha J; Hilarion Fokoue H; Yamaguchi L; Mafud A; Mascarenhas YP; Delerue-Matos C; Borges T; Joanitti GA; Arcanjo D; Kato MJ; Kuckelhaus SAS; Silva MPN; Moraes J; Leite JRSA
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29921756
[TBL] [Abstract][Full Text] [Related]
13. Antitumour efficacy of Piper tuberculatum and piplartine based on the hollow fiber assay.
Bezerra DP; Ferreira PM; Machado CM; de Aquino NC; Silveira ER; Chammas R; Pessoa C
Planta Med; 2015 Jan; 81(1):15-9. PubMed ID: 25519832
[TBL] [Abstract][Full Text] [Related]
14. Piplartine induces inhibition of leukemia cell proliferation triggering both apoptosis and necrosis pathways.
Bezerra DP; Militão GC; de Castro FO; Pessoa C; de Moraes MO; Silveira ER; Lima MA; Elmiro FJ; Costa-Lotufo LV
Toxicol In Vitro; 2007 Feb; 21(1):1-8. PubMed ID: 16971088
[TBL] [Abstract][Full Text] [Related]
15. Apoptotic effect of β-pinene on oral squamous cell carcinoma as one of the major compounds from essential oil of medicinal plant
Machado TQ; Felisberto JRS; Guimarães EF; Queiroz GA; Fonseca ACCD; Ramos YJ; Marques AM; Moreira DL; Robbs BK
Nat Prod Res; 2022 Mar; 36(6):1636-1640. PubMed ID: 33678083
[TBL] [Abstract][Full Text] [Related]
16. Piplartine induces caspase-mediated apoptosis in PC-3 human prostate cancer cells.
Kong EH; Kim YJ; Kim YJ; Cho HJ; Yu SN; Kim KY; Chang JH; Ahn SC
Oncol Rep; 2008 Oct; 20(4):785-92. PubMed ID: 18813819
[TBL] [Abstract][Full Text] [Related]
17. Gas-phase fragmentation of protonated piplartine and its fungal metabolites using tandem mass spectrometry and computational chemistry.
da Silva-Junior EA; Paludo CR; Gouvea DR; Kato MJ; Furtado NAJC; Lopes NP; Vessecchi R; Pupo MT
J Mass Spectrom; 2017 Aug; 52(8):517-525. PubMed ID: 28581151
[TBL] [Abstract][Full Text] [Related]
18. In vivo growth-inhibition of Sarcoma 180 by piplartine and piperine, two alkaloid amides from Piper.
Bezerra DP; Castro FO; Alves AP; Pessoa C; Moraes MO; Silveira ER; Lima MA; Elmiro FJ; Costa-Lotufo LV
Braz J Med Biol Res; 2006 Jun; 39(6):801-7. PubMed ID: 16751987
[TBL] [Abstract][Full Text] [Related]
19. Inhibiting the PI3K/Akt, NF-κB signalling pathways with syringic acid for attenuating the development of oral squamous cell carcinoma cells SCC131.
Velu P; Vijayalakshmi A; Vinothkumar V
J Pharm Pharmacol; 2020 Nov; 72(11):1595-1606. PubMed ID: 32790092
[TBL] [Abstract][Full Text] [Related]
20. Schistosomiasis control using piplartine against Biomphalaria glabrata at different developmental stages.
Rapado LN; Pinheiro Ade S; Lopes PO; Fokoue HH; Scotti MT; Marques JV; Ohlweiler FP; Borrely SI; Pereira CA; Kato MJ; Nakano E; Yamaguchi LF
PLoS Negl Trop Dis; 2013; 7(6):e2251. PubMed ID: 23755312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
